2014
DOI: 10.1507/endocrj.ej13-0463
|View full text |Cite
|
Sign up to set email alerts
|

A higher serum gamma-glutamyl transferase level could be associated with an increased risk of incident osteoporotic fractures in Korean men aged 50 years or older

Abstract: With increasing life expectancies in men and greater comorbidity and mortality after hip fractures in men than in women [2], OFs in men will likely become a significant burden on society and healthcare systems in the future.Gamma-glutamyl transferase (GGT) has long been considered a sensitive marker of hepatic dysfunction or excessive alcohol intake [3]. However, accumulating evidence from epidemiological studies has shown that high levels of serum GGT, even within its reference range, can predict the incidenc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 19 publications
0
12
0
Order By: Relevance
“…GGT exhibited a relatively strong negative statistical significance with BMD at various sites in the current study, and the relationship between GGT and BMD has also been examined in numerous other studies [ 28 , 29 ]. A cross-sectional study conducted in 462 Korean adults demonstrated a negative relationship between serum GGT and BMD [ 30 ], and a large prospective cohort study on 16,036 Korean men aged ≥50 years found that elevated serum GGT levels at baseline were significantly associated with an increased incident of osteoporotic fractures over an average 3-year follow-up period, indicating that higher serum GGT levels may act as an independent risk factor for development of incidental fractures at osteoporosis-related sites in men [ 31 ]. In addition, Niida et al suggested that GGT stimulates the receptor activator of nuclear factor-kappa ß ligand expression and induces osteoclast formation [ 32 ], and GGT overexpression has been linked with accelerated bone resorption and osteoporosis development in transgenic mice [ 33 ], lending weight to the hypothesis that GGT may play a direct role in the pathogenesis of metabolic bone disease.…”
Section: Discussionmentioning
confidence: 99%
“…GGT exhibited a relatively strong negative statistical significance with BMD at various sites in the current study, and the relationship between GGT and BMD has also been examined in numerous other studies [ 28 , 29 ]. A cross-sectional study conducted in 462 Korean adults demonstrated a negative relationship between serum GGT and BMD [ 30 ], and a large prospective cohort study on 16,036 Korean men aged ≥50 years found that elevated serum GGT levels at baseline were significantly associated with an increased incident of osteoporotic fractures over an average 3-year follow-up period, indicating that higher serum GGT levels may act as an independent risk factor for development of incidental fractures at osteoporosis-related sites in men [ 31 ]. In addition, Niida et al suggested that GGT stimulates the receptor activator of nuclear factor-kappa ß ligand expression and induces osteoclast formation [ 32 ], and GGT overexpression has been linked with accelerated bone resorption and osteoporosis development in transgenic mice [ 33 ], lending weight to the hypothesis that GGT may play a direct role in the pathogenesis of metabolic bone disease.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4][5][6][7][8][9][10][11][12][13]18,[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39] International Classification of Disease-10th revision (ICD-10) codes for each disease and the generic name codes for drugs recorded in the NHIS-NSC were used to identify the aforementioned factors at the time of baseline examination. [1][2][3][4][5][6][7][8][9][10][11][12][13]18,[25][26][27][28][29][30][31][32]…”
Section: Data Collectionmentioning
confidence: 99%
“…Along with the abovementioned baseline data, the following factors were additionally sorted out from the database after literature review to assess potential factors that may influence GGT: various types of liver disease (hepatitis, alcoholic liver disease, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, liver cirrhosis, primary or secondary liver cancer, etc), atrial fibrillation, ischemic heart disease, heart failure, cancer, chronic kidney disease, osteoporotic fracture, pregnancy, and antiepileptic drug (phenytoin, phenobarbital, carbamazepine, or valproate) or rifampicin use. [1][2][3][4][5][6][7][8][9][10][11][12][13]18,[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39] International Classification of Disease-10th revision (ICD-10) codes for each disease and the generic name codes for drugs recorded in the NHIS-NSC were used to identify the aforementioned factors at the time of baseline examination.…”
Section: Data Collectionmentioning
confidence: 99%
“…In postmenopausal women urinary GGT excretion exhibited a high correlation with DPD [49]. A large longitudinal study (16,036 Korean men aged ≥ 50 years) demonstrated that a higher serum GGT level was associated with increased development of osteoporotic fractures over a mean 3-year follow-up period [50]. Experimental data indicate that both a deficiency and an excess of GGT result in osteoporosis [49,[51][52][53].…”
Section: Liver-bone Interactionsmentioning
confidence: 99%